Professor Howard Erichson was quoted in Fortune where he discusses why Johnson & Johnson continues to go to trial instead of settle in lawsuits claiming its talc-based products cause ovarian cancer.
“This is not Vioxx. This is not asbestos,” Erichson said. “This is a case where the company wants to defend its brand, and is not going to be anxious to announce a big settlement that appears to concede that the product is harmful.”
